Several US celebrities have turned to Ozempic or Mounjaro, either to help manage Type 2 diabetes or to assist with weight loss. Their before-and-after results have sparked widespread public interest in both medications.
Ozempic (semaglutide) works as a weekly injection through a single mechanism called GLP-1, approved for Type 2 diabetes and weight management. Mounjaro (tirzepatide) uses a dual mechanism — GLP-1 and GIP — which researchers say makes it more effective for weight loss. Here are the celebrities who have spoken publicly about their experiences with both drugs.
